查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1705115

醫療保健分析實驗服務的全球市場:各服務形式，各樣品類型，各終端用戶，各地區，機會，預測，2018年～2032年

Healthcare Analytical Testing Services Market Assessment, By Service Type, By Sample Type, By End-user, By Region, Opportunities and Forecast, 2018-2032F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 242 Pages | 商品交期: 3-5個工作天內

價格

全球醫療分析測試服務市場規模預計將從 2024 年的 83.7 億美元增長到 2032 年的 181.6 億美元，在 2025-2032 年預測期內的複合年增長率為 10.17%。市場成長的動力來自臨床試驗數量的增加、對生物相似藥的日益關注以及製藥公司製造外包的增加。同時，由於對包括基因治療在內的創新和新型治療方案的需求不斷增長，市場需求也在增加。根據美國基因與細胞治療學會統計，截至2024年4月，已核准32種基因治療藥物及28種RNA治療藥物。因此，分析測試服務越來越有必要，因為它們在基因治療產品的特性中發揮關鍵作用，包括評估基因療法產品的效力、純度和穩定性。這確保遵守嚴格的監管標準並加快審批流程。

醫療分析測試服務確保醫療和藥品的安全性和有效性，是藥物開發和製造過程的重要方面。更嚴格的法規、大型製藥公司不斷增加的研發和製造活動外包以及對醫療保健和藥品的一致性品質保證和控制的需求不斷增長，進一步推動了市場的成長。

本報告提供全球醫療保健分析實驗服務市場相關調查，提供市場概要，以及各服務形式，各樣品類型，各終端用戶，各地區趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 計劃的範圍和定義

第2章 調查手法

第3章 摘要整理

第4章 全球醫療保健分析實驗服務市場預測，2018年～2032年

  • 市場規模分析與預測
  • 市場佔有率分析與預測
  • 2024年市場地圖分析
    • 各服務形式
    • 各樣品類型
    • 各終端用戶
    • 各地區

第5章 北美的醫療保健分析實驗服務市場預測，2018年～2032年

  • 市場規模分析與預測
  • 市場佔有率分析與預測
  • 各國市場評估
    • 美國的醫療保健分析實驗服務市場預測，2018年～2032年預測
    • 加拿大
    • 墨西哥

第6章 歐洲的醫療保健分析實驗服務市場預測，2018年～2032年

  • 德國
  • 法國
  • 義大利
  • 英國
  • 俄羅斯
  • 荷蘭
  • 西班牙
  • 土耳其
  • 波蘭

第7章 亞太地區的醫療保健分析實驗服務市場預測，2018年～2032年

  • 印度
  • 中國
  • 日本
  • 澳洲
  • 越南
  • 韓國
  • 印尼
  • 菲律賓

第8章 南美的醫療保健分析實驗服務市場預測，2018年～2032年

  • 巴西
  • 阿根廷

第9章 中東·非洲的醫療保健分析實驗服務市場預測，2018年～2032年

  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章 需求供給分析

第11章 波特的五力分析

第12章 大環境分析

第13章 價格分析

第14章 市場動態

  • 市場促進因素
  • 市場課題

第15章 市場趨勢與發展

第16章 案例研究

第17章 競爭情形

  • 前五名市場領導的競爭矩陣
  • 前五名參與企業的SWOT分析
  • 前10名市場主要企業的形勢
    • Thermo Fisher Scientific, Inc.
    • Charles River Laboratories International, Inc.
    • Eurofins Scientific SE
    • Labcorp Holdings Inc.
    • ICON plc
    • WuXi AppTec Co., Ltd.
    • Medpace Holdings, Inc.
    • Intertek Group plc
    • SGS SA
    • Toxikon, Inc.

第18章 策略性建議

第19章 關於調查公司·免責聲明

Product Code: MX12967

Global healthcare analytical testing services market is projected to witness a CAGR of 10.17% during the forecast period 2025-2032, growing from USD 8.37 billion in 2024 to USD 18.16 billion in 2032. The market's growth can be attributed to the increasing number of clinical trials, rising emphasis on biosimilars, and increasing manufacturing outsourcing by pharmaceutical companies. Meanwhile, the market's demand is also increasing due to the growing requirement for innovative and novel therapeutic solutions, including gene therapies. According to the American Society of Gene and Cell Therapy, 32 gene therapies and 28 RNA therapies have been approved as of April 2024. Thus, bolstering the requirement for analytical testing services as they play a crucial role in characterizing gene therapy products, including assessing their potency, purity, and stability. Thus, ensuring their compliance with stringent regulatory standards and accelerating the approval processes.

Healthcare analytical testing services ensure the safety and efficacy of medical and pharmaceutical products and are an essential aspect of the drug development and manufacturing processes. Rising regulatory stringency, increasing outsourcing of research and development and manufacturing activities by leading pharmaceutical companies, and the rising requirement for consistent quality assurance and control for healthcare and pharmaceutical products are further driving the growth of the market.

Increasing Pharmaceutical Outsourcing Boosts Market Demand

Pharmaceutical and biopharmaceutical companies are increasingly seeking contract research organizations (CROs) to comply with regulatory requirements and minimize internal costs. This increased reliance can also be attributed to the rapid expansion of pharmaceutical industries across the globe. According to India Brand Equity Foundation (IBEF), India has the highest number of United States Food and Drug Administration (US FDA) compliant pharmaceutical plants outside the United States and over 2000 World Health Organization- Good Manufacturing Practices (WHO-GMP) approved facilities.

Additionally, regulatory bodies such as the US FDA are tightening their quality assurance frameworks, necessitating greater testing accuracy and documentation, thus encouraging pharmaceutical companies to partner with external laboratories that provide advanced analytical testing services. The increasing requirement of complex biologics, biosimilars, and personalized therapies is creating additional demand for sophisticated testing protocols that ensure patient safety and product consistency. Thus, outsourcing provides a strategic and economic alternative to pharmaceutical companies that are working on remaining compliant and competitive in the rapidly evolving pharmaceutical industry.

Rising Requirement for Biologics and Biosimilars Supports Market Expansion

Biologics, including monoclonal antibodies, cell and gene therapies, and recombinant proteins, require rigorous analytical characterization as they are sensitive to environmental conditions due to their complex structure. Analytical testing of these products includes structural elucidation, potency assays, impurity profiling, and stability assessment. The rising prevalence of chronic diseases such as cancer, autoimmune disorders, and diabetes are also propelling the requirement for biologics. The American Cancer Society estimates that approximately 2,041,910 new cancer cases will be reported in the United States in 2025. This increase is thus creating the demand for constant quality assurance. Regulatory agencies are mandating extensive analytical data to provide approval to biologic and biosimilar products, resulting in the increased demand for specialized testing services that include chromatography, mass spectrometry, immunoassays, and cell-based assays.

Bioanalytical Testing Services Account for Significant Share of the Market

The growth of the segment can be attributed to its role in the evaluation of pharmacokinetics, pharmacodynamics, and bioequivalence studies during clinical trials. These testing services are essential for determining the absorption, distribution, metabolism, and excretion (ADME) profile of drugs, particularly for novel biosimilars, biologics, and specialty medications. Additionally, rising clinical trial volumes across phases I to IV, especially in oncology, and immunotherapy, are further increasing the demand for bioanalytical testing services. CROs and pharmaceutical companies are heavily investing in automation technologies and high-throughput platforms to meet this rising demand while ensuring regulatory compliance. Additionally, increasing acquisitions of various analytical service providers is also supporting the segment's growth. For instance, in December 2023, Sterling Accuris Wellness Private Limited acquired Vaibhav Analytical Services, an NABL-accredited laboratory that adheres to international standards and serves clients across India. The acquisition aligns with Sterling Accuris Diagnostics' commitment to advance healthcare through innovation and excellence in diagnostics and analytical testing services and allows the company to meet the growing demand for comprehensive testing solutions.

North America Holds Major Market Share

The market's growth in North America can be attributed to the strong presence of leading healthcare and pharmaceutical companies, rising requirement for high-end pharmaceuticals and medical devices to combat the growing threat of various diseases and disorders, and increasing need for regulated drug development processes to meet the safety standards. The growing number of ongoing clinical trials in the region are also positively influencing the market's growth. The demand for complete analytical testing services for biosimilars, vaccine development, and novel drug formulations has also increased in the region. Additionally, the leading service providers in the country are investing in expanding their analytical testing services. For instance, in March 2024, LGM Pharma LLC invested over USD 2 million in standalone analytical testing services (ATS) and expanded these services by 50% while adding suppository manufacturing capabilities to its contract development and manufacturing organization (CDMO) portfolio, at their facility in Texas, United States. The new suppository manufacturing capabilities address the growing demand for specialized drug delivery methods, particularly for geriatric, pediatric, and women's health needs. Such investments further supports the expansion of the market in North America.

Future Market Scenario (2025 - 2032F)

The market is expected to witness significant growth in the coming years as the demand for complex drug development, personalized medicine, and regulatory compliance increases. Increased investments in healthcare infrastructure by developing countries is expected to provide lucrative growth opportunities for the market. Meanwhile, Advances in automation, AI-integrated platforms, and high-throughput screening, among others, are aiding in improving the accuracy and efficiency of methodologies used in healthcare analytical testing.

The advent of cloud computing and big data analytics are expected to facilitate transformative changes in data management for healthcare analytical testing by allowing real-time analysis. Meanwhile, strategic mergers and acquisitions among contract research organizations (CROs), the entry of new players, and the expansion of service portfolios by various services providers are also expected to positively influence the market's expansion.

Key Players Landscape and Outlook

The key players of the market are focusing on strategic alliances and partnerships as they foster innovation, expand service portfolios, and enhance the ability of companies to meet regulatory requirements. By pooling resources and expertise, companies are also able to develop more precise and efficient analytical testing methods, which are crucial for ensuring the safety and efficacy of medical devices and pharmaceuticals.

For instance, in March 2024, Charles River Laboratories International, Inc. partnered with Wheeler Bio to combine their antibody discovery services with Wheeler's portable CMC platform to accelerate therapeutic discoveries. The strategic agreement offers a comprehensive solution that connects preclinical development, clinical manufacturing, and release testing processes. By incorporating CMC development early in the discovery phase, companies developing therapeutic solutions can leverage phase-appropriate manufacturing and analytics.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Healthcare Analytical Testing Services Market Outlook, 2018-2032F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Service Type
      • 4.2.1.1. Bioanalytical Testing Services
        • 4.2.1.1.1. Pharmacokinetics (PK)
        • 4.2.1.1.2. Pharmacodynamics (PD)
        • 4.2.1.1.3. Bioavailability (BA)
        • 4.2.1.1.4. Bioequivalence (BE)
        • 4.2.1.1.5. Bioassays
        • 4.2.1.1.6. Others
      • 4.2.1.2. Physical Characterization
        • 4.2.1.2.1. Particle Size Analysis
        • 4.2.1.2.2. Thermal Analysis
        • 4.2.1.2.3. Surface Area Analysis
        • 4.2.1.2.4. Others
      • 4.2.1.3. Stability Testing
      • 4.2.1.4. Raw Material Testing
      • 4.2.1.5. Microbial Testing
        • 4.2.1.5.1. Bioburden Testing
        • 4.2.1.5.2. Sterility Testing
        • 4.2.1.5.3. Endotoxin Testing
        • 4.2.1.5.4. Microbial Identification
        • 4.2.1.5.5. Others
      • 4.2.1.6. Environmental Monitoring
      • 4.2.1.7. Method Development and Validation
      • 4.2.1.8. Other Services
    • 4.2.2. By Sample Type
      • 4.2.2.1. Raw Material
      • 4.2.2.2. Finished Products
        • 4.2.2.2.1. Monoclonal Antibodies
        • 4.2.2.2.2. Vaccines
        • 4.2.2.2.3. Cell and Gene Therapy Products
    • 4.2.3. By End-user
      • 4.2.3.1. Pharmaceutical and Biotechnology Companies
      • 4.2.3.2. Medical Device Manufacturers
      • 4.2.3.3. Contract Research Organizations (CROs)
      • 4.2.3.4. Academic and Research Institutes
      • 4.2.3.5. Others
    • 4.2.4. By Region
      • 4.2.4.1. North America
      • 4.2.4.2. Europe
      • 4.2.4.3. Asia-Pacific
      • 4.2.4.4. South America
      • 4.2.4.5. Middle East and Africa
    • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
  • 4.3. Market Map Analysis, 2024
    • 4.3.1. By Service Type
    • 4.3.2. By Sample Type
    • 4.3.3. By End-user
    • 4.3.4. By Region

5. North America Healthcare Analytical Testing Services Market Outlook, 2018-2032F

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Service Type
      • 5.2.1.1. Bioanalytical Testing Services
        • 5.2.1.1.1. Pharmacokinetics (PK)
        • 5.2.1.1.2. Pharmacodynamics (PD)
        • 5.2.1.1.3. Bioavailability (BA)
        • 5.2.1.1.4. Bioequivalence (BE)
        • 5.2.1.1.5. Bioassays
        • 5.2.1.1.6. Others
      • 5.2.1.2. Physical Characterization
        • 5.2.1.2.1. Particle Size Analysis
        • 5.2.1.2.2. Thermal Analysis
        • 5.2.1.2.3. Surface Area Analysis
        • 5.2.1.2.4. Others
      • 5.2.1.3. Stability Testing
      • 5.2.1.4. Raw Material Testing
      • 5.2.1.5. Microbial Testing
        • 5.2.1.5.1. Bioburden Testing
        • 5.2.1.5.2. Sterility Testing
        • 5.2.1.5.3. Endotoxin Testing
        • 5.2.1.5.4. Microbial Identification
        • 5.2.1.5.5. Others
      • 5.2.1.6. Environmental Monitoring
      • 5.2.1.7. Method Development and Validation
      • 5.2.1.8. Other Services
    • 5.2.2. By Sample Type
      • 5.2.2.1. Raw Material
      • 5.2.2.2. Finished Products
        • 5.2.2.2.1. Monoclonal Antibodies
        • 5.2.2.2.2. Vaccines
        • 5.2.2.2.3. Cell and Gene Therapy Products
    • 5.2.3. By End-user
      • 5.2.3.1. Pharmaceutical and Biotechnology Companies
      • 5.2.3.2. Medical Device Manufacturers
      • 5.2.3.3. Contract Research Organizations (CROs)
      • 5.2.3.4. Academic and Research Institutes
      • 5.2.3.5. Others
    • 5.2.4. By Country Share
      • 5.2.4.1. United States
      • 5.2.4.2. Canada
      • 5.2.4.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States Healthcare Analytical Testing Services Market Outlook, 2018-2032F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Service Type
          • 5.3.1.2.1.1. Bioanalytical Testing Services
          • 5.3.1.2.1.1.1. Pharmacokinetics (PK)
          • 5.3.1.2.1.1.2. Pharmacodynamics (PD)
          • 5.3.1.2.1.1.3. Bioavailability (BA)
          • 5.3.1.2.1.1.4. Bioequivalence (BE)
          • 5.3.1.2.1.1.5. Bioassays
          • 5.3.1.2.1.1.6. Others
          • 5.3.1.2.1.2. Physical Characterization
          • 5.3.1.2.1.2.1. Particle Size Analysis
          • 5.3.1.2.1.2.2. Thermal Analysis
          • 5.3.1.2.1.2.3. Surface Area Analysis
          • 5.3.1.2.1.2.4. Others
          • 5.3.1.2.1.3. Stability Testing
          • 5.3.1.2.1.4. Raw Material Testing
          • 5.3.1.2.1.5. Microbial Testing
          • 5.3.1.2.1.5.1. Bioburden Testing
          • 5.3.1.2.1.5.2. Sterility Testing
          • 5.3.1.2.1.5.3. Endotoxin Testing
          • 5.3.1.2.1.5.4. Microbial Identification
          • 5.3.1.2.1.5.5. Others
          • 5.3.1.2.1.6. Environmental Monitoring
          • 5.3.1.2.1.7. Method Development and Validation
          • 5.3.1.2.1.8. Other Services
        • 5.3.1.2.2. By Sample Type
          • 5.3.1.2.2.1. Raw Material
          • 5.3.1.2.2.2. Finished Products
          • 5.3.1.2.2.2.1. Monoclonal Antibodies
          • 5.3.1.2.2.2.2. Vaccines
          • 5.3.1.2.2.2.3. Cell and Gene Therapy Products
        • 5.3.1.2.3. By End-user
          • 5.3.1.2.3.1. Pharmaceutical and Biotechnology Companies
          • 5.3.1.2.3.2. Medical Device Manufacturers
          • 5.3.1.2.3.3. Contract Research Organizations (CROs)
          • 5.3.1.2.3.4. Academic and Research Institutes
          • 5.3.1.2.3.5. Others
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Healthcare Analytical Testing Services Market Outlook, 2018-2032F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Turkey
  • 6.9. Poland

7. Asia-Pacific Healthcare Analytical Testing Services Market Outlook, 2018-2032F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America Healthcare Analytical Testing Services Market Outlook, 2018-2032F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa Healthcare Analytical Testing Services Market Outlook, 2018-2032F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa

10. Demand Supply Analysis

11. Porter's Five Forces Analysis

12. PESTLE Analysis

13. Pricing Analysis

14. Market Dynamics

  • 14.1. Market Drivers
  • 14.2. Market Challenges

15. Market Trends and Developments

16. Case Studies

17. Competitive Landscape

  • 17.1. Competition Matrix of Top 5 Market Leaders
  • 17.2. SWOT Analysis for Top 5 Players
  • 17.3. Key Players Landscape for Top 10 Market Players
    • 17.3.1. Thermo Fisher Scientific, Inc.
      • 17.3.1.1. Company Details
      • 17.3.1.2. Key Management Personnel
      • 17.3.1.3. Products and Services
      • 17.3.1.4. Financials (As Reported)
      • 17.3.1.5. Key Market Focus and Geographical Presence
      • 17.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 17.3.2. Charles River Laboratories International, Inc.
    • 17.3.3. Eurofins Scientific SE
    • 17.3.4. Labcorp Holdings Inc.
    • 17.3.5. ICON plc
    • 17.3.6. WuXi AppTec Co., Ltd.
    • 17.3.7. Medpace Holdings, Inc.
    • 17.3.8. Intertek Group plc
    • 17.3.9. SGS SA
    • 17.3.10. Toxikon, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

18. Strategic Recommendations

19. About Us and Disclaimer

List of Tables

  • Table 1. Competition Matrix of Top 5 Market Leaders
  • Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 2. Global Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
  • Figure 3. Global Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
  • Figure 4. Global Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 5. Global Healthcare Analytical Testing Services Market Share (%), By Region, 2018-2032F
  • Figure 6. North America Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 7. North America Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
  • Figure 8. North America Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
  • Figure 9. North America Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 10. North America Healthcare Analytical Testing Services Market Share (%), By Country, 2018-2032F
  • Figure 11. United States Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 12. United States Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
  • Figure 13. United States Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
  • Figure 14. United States Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 15. Canada Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 16. Canada Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
  • Figure 17. Canada Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
  • Figure 18. Canada Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 19. Mexico Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 20. Mexico Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
  • Figure 21. Mexico Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
  • Figure 22. Mexico Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 23. Europe Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 24. Europe Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
  • Figure 25. Europe Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
  • Figure 26. Europe Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 27. Europe Healthcare Analytical Testing Services Market Share (%), By Country, 2018-2032F
  • Figure 28. Germany Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 29. Germany Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
  • Figure 30. Germany Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
  • Figure 31. Germany Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 32. France Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 33. France Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
  • Figure 34. France Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
  • Figure 35. France Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 36. Italy Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 37. Italy Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
  • Figure 38. Italy Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
  • Figure 39. Italy Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 40. United Kingdom Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 41. United Kingdom Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
  • Figure 42. United Kingdom Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
  • Figure 43. United Kingdom Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 44. Russia Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 45. Russia Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
  • Figure 46. Russia Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
  • Figure 47. Russia Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 48. Netherlands Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 49. Netherlands Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
  • Figure 50. Netherlands Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
  • Figure 51. Netherlands Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 52. Spain Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 53. Spain Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
  • Figure 54. Spain Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
  • Figure 55. Spain Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 56. Turkey Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 57. Turkey Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
  • Figure 58. Turkey Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
  • Figure 59. Turkey Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 60. Poland Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 61. Poland Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
  • Figure 62. Poland Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
  • Figure 63. Poland Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 64. South America Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 65. South America Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
  • Figure 66. South America Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
  • Figure 67. South America Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 68. South America Healthcare Analytical Testing Services Market Share (%), By Country, 2018-2032F
  • Figure 69. Brazil Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 70. Brazil Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
  • Figure 71. Brazil Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
  • Figure 72. Brazil Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 73. Argentina Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 74. Argentina Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
  • Figure 75. Argentina Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
  • Figure 76. Argentina Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 77. Asia-Pacific Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 78. Asia-Pacific Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
  • Figure 79. Asia-Pacific Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
  • Figure 80. Asia-Pacific Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 81. Asia-Pacific Healthcare Analytical Testing Services Market Share (%), By Country, 2018-2032F
  • Figure 82. India Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 83. India Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
  • Figure 84. India Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
  • Figure 85. India Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 86. China Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 87. China Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
  • Figure 88. China Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
  • Figure 89. China Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 90. Japan Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 91. Japan Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
  • Figure 92. Japan Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
  • Figure 93. Japan Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 94. Australia Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 95. Australia Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
  • Figure 96. Australia Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
  • Figure 97. Australia Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 98. Vietnam Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 99. Vietnam Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
  • Figure 100. Vietnam Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
  • Figure 101. Vietnam Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 102. South Korea Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 103. South Korea Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
  • Figure 104. South Korea Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
  • Figure 105. South Korea Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 106. Indonesia Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 107. Indonesia Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
  • Figure 108. Indonesia Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
  • Figure 109. Indonesia Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 110. Philippines Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 111. Philippines Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
  • Figure 112. Philippines Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
  • Figure 113. Philippines Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 114. Middle East & Africa Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 115. Middle East & Africa Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
  • Figure 116. Middle East & Africa Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
  • Figure 117. Middle East & Africa Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 118. Middle East & Africa Healthcare Analytical Testing Services Market Share (%), By Country, 2018-2032F
  • Figure 119. Saudi Arabia Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 120. Saudi Arabia Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
  • Figure 121. Saudi Arabia Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
  • Figure 122. Saudi Arabia Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 123. UAE Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 124. UAE Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
  • Figure 125. UAE Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
  • Figure 126. UAE Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 127. South Africa Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 128. South Africa Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
  • Figure 129. South Africa Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
  • Figure 130. South Africa Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 131. By Service Type Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 132. By Sample Type Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 133. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 134. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024